AI in Medical Diagnostics Market to grow at a CAGR of 27.4% during 2026 to 2035; Driven by Rising Adoption of Artificial Intelligence in Healthcare and Increasing Demand for Advanced Diagnostic Solutions

AI in Medical Diagnostics Market Highlights

AI in Medical Diagnostics Market reached USD 2.15 billion in 2025 and is projected to grow to USD 24.23 billion by 2035, expanding at a compound annual growth rate (CAGR) of 27.4% between 2026 and 2035. Market value is expected to reach USD 2.74 billion in 2026 as the first year of the forecast period.

MRFR recognizes the following companies as the key players in the global AI in medical diagnostics market - Siemens Healthineers, Vuno, Inc., Nanox Imaging LTD (Zebra Medical Vision, Inc.), Riverain Technologies, Aidoc, AliveCor Inc., Neural Analytics, Digital Diagnostics, Inc., Imagen Technologies, GE Healthcare, Enlitic, and InformAI.

The growing demand for AI to be used in medical diagnosis to reduce errors, the scarcity of healthcare experts, and the rising prevalence of chronic diseases are what are driving the growth of AI in the medical diagnostics market.

Furthermore, there should be a lot of room for expansion for the AI market in medical diagnostics due to the potential for growth in developing economies and the rise in cross-industry partnerships and collaborations. In addition, the strong growth potential of emerging economies and the increasing number of cross-industry alliances and collaborations are expected to provide significant growth chances for this market.

Segment Analysis

The global AI in the medical diagnostics market has been segmented into component, application, and end user.

Based on component, the market is segmented into Software, Hardware, and Services. The software segment was attributed to holding the largest market share in 2023. The main component of artificial intelligence is software, which allows it to analyze data more quickly and accurately. Because AI-based software is added to diagnostic devices such as MRI and CT scanners to enable fast data processing and analysis, the software component has a significant market share in AI in medical diagnostics.

Based on application, the market is segmented into In Vivo Diagnostics and In Vitro Diagnostics. The in vivo diagnostics segment was attributed to holding the largest market share in 2023 due to issues with maternity during childbirth as well as the increase in infectious and chronic illness rates. The neurology category has the largest percentage of in-vivo diagnostic applications due to AI's exceptional efficacy in diagnosing a wide range of neurological conditions, including brain tumors and cancer.

Based on end user, the global AI in medical diagnostics market has been segmented into Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories, and Others. The hospitals segment was expected to hold the largest market share in 2023. The significant share of AI in medical diagnostics market is attributed to the growing number of patients undergoing diagnostic procedures in hospitals, the strong financial standing of large hospitals to acquire pricey AI-based software & services, and the growing physician shortage.

Regional Analysis

The global AI in medical diagnostics market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe AI in medical diagnostics market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The AI in medical diagnostics market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World AI in medical diagnostics market comprises the Middle East, Africa, and Latin America.

The North American regional sector maintained the largest market share for AI in medical diagnostics because of the area's developed medical facilities and well-established healthcare infrastructure, as well as the accessibility of cutting-edge diagnostic software, the expanding healthcare industry, and the growing acceptance of AI-guided and minimally invasive surgical techniques.

Moreover, the Europe market has been persistently growing over the forecast period. A number of factors contribute to this high growth rate: major players in emerging markets have adopted growth strategies; the infrastructure for medical diagnostics has become digital; the number of older people is rising; the incidence of cancer is rising; and the government has put in place supportive measures to encourage the use of cutting-edge technologies in healthcare.

Additionally, Asia Pacific is anticipated to experience the quickest growth over the forecast period. This can be linked to the expansion tactics used by major businesses, the region's aging population, the digitization of the infrastructure for medical diagnostics, and the rising uptake of AI technology as a result of beneficial government efforts.

Furthermore, the rest of the world's AI in medical diagnostics market is divided into the Middle East, Africa, and Latin America. The rest of the world held a significant share in the global AI in medical diagnostics market due to the region's increasing prevalence of chronic illnesses and the skyrocketing use of modern technology in healthcare sectors. The use of AI-based solutions is increasing in the region as a result of the direct correlation between the rise in chronic conditions and the need for accurate diagnosis and treatment.

Key Findings of the Study

• Natural language processing applied to unstructured radiology and pathology reports is expanding at a 29.6% CAGR.


• Multimodal foundation models remain early-stage but attracted the majority of 2025 venture rounds above USD 50 million.


• North America accounts for 42.5% of global revenue


• Asia-Pacific advances at a 31.8% CAGR, the fastest of any region


• Middle East & Africa generated roughly USD 0.10 billion in 2025, largely from Gulf state hospital programs